1988 Outstanding Contributions in a Selected Area of Research
Herbert K. Naito will receive the 16th AACC Award for Outstanding Contributions to Clinical Chemistry in a Selected Area of Research. This award is sponsored by Roche Diagnostic Systems.
Dr. Naito was born in Honolulu, HI. He received his B.A. and M.A. degrees from the University of Northern Colorado in Greeley, CO. He was awarded a Ph.D. degree in physiology from Iowa State University of Science and Technology, Ames, IA. As a fellow of the American Heart Association, he completed his two-year postdoctoral training in the Division of Research (Experimental Pathology) at The Cleveland Clinic Foundation, Cleveland, OH. He recently obtained his M.B.A. degree from Lake Erie College, Painesville, OH.
Dr. Naito currently heads the section of lipid, nutrition, and metabolic diseases in the Department of Biochemistry at The Cleveland Clinic Foundation. He is also a clinical consultant in the Department of Cardiology and a member of the graduate faculty at Cleveland State University, where he holds the appointment of clinical professor of chemistry.
He has been active as a fellow and a member of the board of directors of the American College of Nutrition, the Council on Arteriosclerosis of the American Heart Association, the American Association for Clinical Scientists, the National Academy of Clinical Biochemistry, and the American Association of Experimental Pathologists. He also is actively involved in the American Association for Clinical Chemistry and currently is a member of the board of directors. He served two terms as president of the N.E. Ohio Section of AACC and as a member of council. He is also a member of the New York Academy of Sciences, the Society for Experimental Biology and Medicine, the American Institute of Nutrition, and the Endocrine Society. He currently serves on the editorial boards of Clinical Physiology and Biochemistry; Journal of the American College of Nutrition; Atherogenesis; Trace Metals in Medicine; Clinical Chemistry; and Journal of Clinical Laboratory Analysis.
Dr. Naito’s intense research interest in coronary heart disease and its related risk factors has led him to publish more than 160 scientific papers and to edit five books. His major focus on lipids, lipoproteins, and apolipoproteins has led to numerous awards, including the American Association for Clinical Chemistry Young Investigator Award (1977), the National Academy of Clinical Biochemistry George Grannis Award (1981), and the American Association for Clinical Chemistry 1987 Outstanding Speaker Award. He is listed in Who’s Who in Frontiers of Science and Technology; Who’s Who in the Midwest; Who’s Who in America; and Who’s Who in Society. He currently serves on the National Institutes of Health Steering Committee on the Corporative Clinical Trial on Progressive Renal Disease. He recently was appointed chairman of the Laboratory Standardization Panel of the National Institutes of Health, National Cholesterol Education Program. He also serves as an active educator for the American Society of Clinical Pathologists, the College of American Pathologists, and the American Association for Clinical Chemistry. He serves as a consultant on the Chemistry Resource Committee of the College of American Pathologists. His major, immediate, and long-term objectives are to disseminate accurate information to practicing laboratorians and physicians so that they can remain at the cutting edge of technology, science, and new developments in medicine.
1981 The George F. Grannis Award For Excellence In Research And Scientific Publication
Herbert K. Naito, PhD, FACB was honored with AACC's 1981 George F. Grannis Award for Excellence in Research and Scientific Publication.
1977 Outstanding Scientific Achievements by a Young Investigator
Dr. Naito recieved AACC's award for scientific achievements by a young investigator in 1977.